Home » Stocks » PRTX

Protalex, Inc. (PRTX)

Stock Price: $0.0076 USD 0.0000 (0.00%)
Updated Jan 7, 2021 9:30 AM EST - Market closed
Market Cap 473
Revenue (ttm) n/a
Net Income (ttm) -4.65M
Shares Out 47.33M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 7
Last Price $0.0076
Previous Close $0.0000
Change ($) 0.0000
Change (%) 0.00%
Day's Open -
Day's Range 0.0003 - 0.0076
Day's Volume 0
52-Week Range 0.0001 - 0.0100


There are no news available yet.

About PRTX

Protalex focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of pati... [Read more...]

Drug Manufacturers - Other
IPO Date
Jan 11, 2000
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

Financial Statements